Zaorsky Nicholas G, Ricco Anthony G, Churilla Thomas M, Horwitz Eric M, Den Robert B
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
Future Oncol. 2016 Nov;12(22):2643-2657. doi: 10.2217/fon-2016-0131. Epub 2016 Jul 29.
To analyze malpractice trials in radiation oncology and assess how ASTRO APEx and RO-ILS™ apply to such cases.
The Westlaw database was reviewed using PICOS/PRISMA methods. Fisher's exact and Mann-Whitney U tests were used to find factors associated with outcomes.
Of 34 cases identified, external beam was used in 26 (77%). The most common factors behind malpractice were excessive toxicity (80%) and lack of informed consent (66%). ASTRO APEx pillars and ROI-LS had applicability to all but one case. Factors favoring the defendant included statute of limitations (odds ratio: 8.1; 95% CI: 1.3-50); those favoring the plaintiff included patient death (odds ratio: 0.7; 95% CI: 0.54-0.94).
APEx and RO-ILS are applicable to malpractice trials in radiation oncology.
分析放射肿瘤学中的医疗事故审判，并评估美国放射肿瘤学会（ASTRO）的《放射肿瘤学实践的循证途径和共识声明》（APEx）以及放射肿瘤学信息与学习系统（RO-ILS™）如何适用于此类案件。
使用PICOS/PRISMA方法对Westlaw数据库进行检索。采用Fisher精确检验和Mann-Whitney U检验来找出与结果相关的因素。
在确定的34个案例中，26个（77%）使用了外照射。医疗事故背后最常见的因素是毒性过大（80%）和缺乏知情同意（66%）。除了一个案例外，ASTRO APEx的支柱内容和ROI-LS适用于所有案例。有利于被告的因素包括诉讼时效（优势比：8.1；95%置信区间：1.3 - 50）；有利于原告的因素包括患者死亡（优势比：0.7；95%置信区间：0.54 - 0.94）。
APEx和RO-ILS适用于放射肿瘤学中的医疗事故审判。
